Key result
Intracranial atherosclerotic stenosis regression is linked to a ~0.14 mm decrease in maximum carotid IMT.
Why the study?
The association between carotid intima-media thickness and intracranial atherosclerotic stenosis responses to medical treatment was unclear.
Does the change in carotid intima-media thickness correlate with intracranial atherosclerotic stenosis response to medical treatment in patients with symptomatic intracranial arterial stenosis?
Observational (n=85)
Blinded to clinical information
Yes
Does the change in carotid intima-media thickness correlate with intracranial atherosclerotic stenosis response to medical treatment in patients with symptomatic intracranial arterial stenosis?
The response of carotid intima-media thickness to medical treatment correlates with the response of intracranial atherosclerosis, suggesting CIMT changes may reflect intracranial plaque behavior.
Answers are grounded in this paper and cite their sources.
CIMT may mark ICAS response to cilostazol; leaves open any role in guiding therapy pending prospective validation.
BACKGROUND AND PURPOSE: Intracranial atherosclerotic stenosis (ICAS) is considered as a major cause of stroke. The carotid intima-media thickness (CIMT), which accurately reflects the burden of generalized atherosclerosis, is also associated with stroke. The aim of this study was to determine the association between the CIMT and ICAS responses to medical treatment. METHODS: This study constituted part of the "Trial of cilostazol in symptomatic intracranial arterial stenosis"-2 that evaluated the ICAS response after randomized antiplatelet treatment. Magnetic resonance angiography and CIMT measurement were performed at baseline and after 7 months of treatment. CIMT was measured using semiautomated software, and was presented as maximum (CIMT-max) and average (CIMT-ave) values. The change in CIMT was compared relative to the ICAS response (i.e., progression, no-change, and regression). Ordinal logistic regression and analysis of covariance (ANCOVA) were used to analyze the association between the responses. RESULTS: Among the 101 enrolled patients, 85 underwent follow-up CIMT measurement. CIMT increased most in the ICAS progression group (CIMT-max: 0.09±0.23, CIMT-ave: 0.04±0.12), and to a lesser degree in the no-change group (CIMT-max: 0.02±0.16, CIMT-ave: 0.02±0.11), but decreased in patients with ICAS regression (CIMT-max: -0.04±0.11, CIMT-ave: -0.03±0.07; CIMT-max: p=0.010, CIMT-ave: p=0.015). Ordinal logistic regression analysis demonstrated that the change in CIMT-max was independently associated with the ICAS response (p=0.032). However, the ANCOVA revealed that the reverse was not true, in that the ICAS response was not independently associated with the change in CIMT after adjusting for confounding factors. CONCLUSIONS: The ICAS response may be associated with the CIMT response to medical treatment.
No takes yet. Share an insight, caveat, or question.
Kwon et al. (2013) conducted an observational in Ischemic stroke with symptomatic intracranial atherosclerotic stenosis (ICAS) (n=85). ICAS regression vs. ICAS progression was evaluated on Change in maximum carotid intima-media thickness (CIMT-max) (MD 0.14, p=0.037). Regression of intracranial atherosclerotic stenosis after 7 months of medical treatment was associated with a significant decrease in maximum carotid intima-media thickness compared to ICAS progression.
Synapse has enriched 10 related papers. Consider them for comparative context: